Is FEV1 associated with quality of life in children with cystic fibrosis? An original article

被引:0
|
作者
Shirzadi, Rohola [1 ]
Navaei, Safoura [1 ]
Modaresi, Mohammadreza [1 ]
Masiha, Farzad [2 ]
机构
[1] Univ Tehran Med Sci, Childrens Med Ctr, Pediat Resp & Sleep Med Res Ctr, Tehran, Iran
[2] Mazandaran Univ Med Sci, Pediat Infect Dis Res Ctr, Sari, Iran
来源
IMMUNOPATHOLOGIA PERSA | 2020年 / 6卷 / 01期
关键词
Pulmonary function; Cystic fibrosis; Spirometry; Quality of life; LUNG-FUNCTION; WALK TEST; STRESS;
D O I
10.15171/ipp.2020.06
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Cystic fibrosis (CF) is a serious genetic life-shortening disease. Quality of life (QoL) measurement related to CF children is a relatively new field of research, which includes the patient's perspective in research and clinical practice. Objectives: This study aimed to evaluate the QoL in children with CF and its association with FEV1 (forced expiratory volume in 1 second). Patients and Methods: This cross-sectional study was carried out on 7-14 years old children with CF attending children's medical center from March 2017 to March 2018. Throat swab cultures and spirometry evaluation was performed for all patients. FEV1 was determined and the 6-min walk test (6MWT) was conducted. The patient's psychological status was assessed using the Persian version of pediatric QoL inventory. ANOVA, t test, and chisquare tests were used for data analysis. Results: Seventy-six subjects with the mean age of 10.49 +/- 3.18 years were studied since 59% of them (n=44) were boys. The mean total QoL was 65.34 +/- 17.73. Patients with lower pulmonary function had a lower QoL. There was a significant association between FEV1 and school and emotional functioning (P = 0 .005 and P=0.002, respectively). A significant association was found between SPO2 (peripheral capillary oxygen saturation) reduction after 6MWT and FEV1 decline (P = 0.001). Additionally, a significant association was detected between FEV1 and the distance walked during 6MWT (P = 0.030). Conclusion: Regarding the association between pulmonary function and QoL in CF patients and lower QoL score in our study, the importance of assessing pulmonary function in these patients should not be neglected.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial
    Kriemler, Susi
    Kieser, Stephanie
    Junge, Sibylle
    Ballmann, Manfred
    Hebestreit, Alexandra
    Schindler, Christian
    Stuessi, Christoph
    Hebestreit, Helge
    JOURNAL OF CYSTIC FIBROSIS, 2013, 12 (06) : 714 - 720
  • [32] Psychiatric morbidity and quality of life in children and adolescents with cystic fibrosis
    Senses-Dinc, Gulser
    Ozcelik, Ugur
    Cak, Tuna
    Dogru-Ersoz, Deniz
    Cop, Esra
    Yalcin, Ebru
    Cengel-Kultur, Ebru
    Pekcan, Sevgi
    Kiper, Nural
    Unal, Fatih
    TURKISH JOURNAL OF PEDIATRICS, 2018, 60 (01) : 32 - 40
  • [33] Abnormal Lung Clearance Index in Cystic Fibrosis Children with Normal FEV1 and Single-Breath Nitrogen Washout Test
    Ajay S. Kasi
    Choo Phei Wee
    Thomas G. Keens
    Danieli B. Salinas
    Lung, 2021, 199 : 37 - 41
  • [34] Abnormal Lung Clearance Index in Cystic Fibrosis Children with Normal FEV1 and Single-Breath Nitrogen Washout Test
    Kasi, Ajay S.
    Wee, Choo Phei
    Keens, Thomas G.
    Salinas, Danieli B.
    LUNG, 2021, 199 (01) : 37 - 41
  • [35] Cystic fibrosis patients at risk for disease progression marked by decline in FEV1% predicted: development of the cystic fibrosis risk of disease progression score
    Marsteller, Nathan L.
    Nussbaum, Eliezer
    Morphew, Tricia
    Randhawa, Inderpal S.
    JOURNAL OF THORACIC DISEASE, 2019, 11 (12) : 5557 - 5565
  • [36] Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis
    Dube, Bruno-Pierre
    S-Carricart, Maite
    Levesque, Jonathan
    Poirier, Claude
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [37] Electronic home monitoring of children with cystic fibrosis to detect and treat acute pulmonary exacerbations and its effect on 1-year FEV1
    Yanaz, Muruvvet
    Yegit, Cansu Yilmaz
    Gulieva, Aynur
    Kalyoncu, Mine
    Selcuk, Merve
    Uzunoglu, Burcu
    Tastan, Gamze
    Ergenekon, Almala Pinar
    Gokdemir, Yasemin
    Eralp, Ela Erdem
    Karakoc, Fazilet
    Karadag, Bulent
    JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (02) : 329 - 333
  • [38] Heterogeneity in Survival in Adult Patients With Cystic Fibrosis With FEV1 < 30% of Predicted in the United States
    Ramos, Kathleen J.
    Quon, Bradley S.
    Heltshe, Sonya L.
    Mayer-Hamblett, Nicole
    Lease, Erika D.
    Aitken, Moira L.
    Weiss, Noel S.
    Goss, Christopher H.
    CHEST, 2017, 151 (06) : 1320 - 1328
  • [39] Quality of life in patients with cystic fibrosis
    deJong, W
    Kaptein, AA
    vanderSchans, CP
    Mannes, GPM
    vanAalderen, WMC
    Grevink, RG
    Koeter, GH
    PEDIATRIC PULMONOLOGY, 1997, 23 (02) : 95 - 100
  • [40] Clinical Use of Tobramycin Inhalation Solution ( TOBI1) Shows Sustained Improvement in FEV1 in Cystic Fibrosis
    Konstan, Michael W.
    Wagener, Jeffrey S.
    Pasta, David J.
    Millar, Stefanie J.
    Morgan, Wayne J.
    PEDIATRIC PULMONOLOGY, 2014, 49 (06) : 529 - 536